Haemodynamic effects of sacubitril/valsartan in advanced heart failure
Abstract Aims The angiotensin receptor–neprilysin inhibitor (ARNI), sacubitril/valsartan, has been shown to be effective in treatment of patients with heart failure (HF), but limited data are available in patients with advanced disease. This retrospective observational study assessed the effects of...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2022-04-01
|
| Col·lecció: | ESC Heart Failure |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ehf2.13755 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|